Placental transfer and other physiologic studies with intravenous butorphanol in the anesthetized pregnant ewe.
In clinical evaluation, butorphanol has been used in labor pain with analgesia and newborn outcome comparable to meperidine. Only limited placental transfer studies have been done in the human. The placental transfer and effect of intravenous butorphanol (2 mg) on avrious cardiovascular parameters were determined in anesthetized sheep. Serum butorphanol was determined by a specific radioimmunoassay. Butorphanol 2 mg intravenously did not affect the measured cardiovascular parameters in either ewe or fetus. Butorphanol could be demonstrated in the fetal circulation within one minute of administration and appeared to reach equilibrium in the maternal circulation rapidly and to remain in equilibrium thereafter. A biexponential decline of butorphanol was observed in the maternal serum with a terminal elimination half-life of 50 minutes. The data suggest butorphanol distribution in the pregment ewe can be conceptualized by the two compartment model, with the fetus as part of the peripheral compartment. These studies support the clinical finding from other studies that butorphanol appears to be a safe analgesic for use in labor pain.
D000758:Anesthesia; D000818:Animals; D002077:Butorphanol / Q000378:metabolism* / Q000494:pharmacology; D005260:Female; D005333:Fetus / Q000378:metabolism; D007700:Kinetics; D008431:Maternal-Fetal Exchange; D009019:Morphinans / Q000378:metabolism*; D010920:Placenta / Q000378:metabolism; D011247:Pregnancy; D012756:Sheep
D009019:Morphinans; D002077:Butorphanol